Gateway Investment Advisers LLC lowered its stake in shares of Cooper Companies Inc (NYSE:COO) by 54.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,034 shares of the medical device company’s stock after selling 1,247 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Cooper Companies were worth $307,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Ossiam acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $25,000. Flagship Harbor Advisors LLC boosted its holdings in shares of Cooper Companies by 62.5% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 30 shares in the last quarter. Kings Point Capital Management acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $27,000. Evolution Wealth Advisors LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $34,000. Finally, NumerixS Investment Technologies Inc acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $34,000. 95.82% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts have weighed in on the company. Wells Fargo & Co raised their target price on Cooper Companies from $356.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Raymond James reaffirmed a “buy” rating on shares of Cooper Companies in a report on Monday, August 26th. Piper Jaffray Companies set a $360.00 target price on Cooper Companies and gave the company a “buy” rating in a report on Friday, August 30th. KeyCorp reduced their target price on Cooper Companies from $351.00 to $348.00 and set an “overweight” rating on the stock in a report on Friday, October 11th. Finally, ValuEngine downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $326.00.

Shares of COO opened at $287.81 on Monday. Cooper Companies Inc has a 52 week low of $228.65 and a 52 week high of $344.32. The stock has a market capitalization of $14.49 billion, a price-to-earnings ratio of 25.03, a PEG ratio of 2.30 and a beta of 0.91. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.73 and a current ratio of 1.29. The stock has a fifty day moving average of $299.22 and a 200-day moving average of $309.91.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, August 29th. The medical device company reported $3.23 EPS for the quarter, beating the Zacks’ consensus estimate of $3.16 by $0.07. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. The company had revenue of $679.40 million during the quarter, compared to analysts’ expectations of $687.60 million. During the same period in the prior year, the company earned $3.00 EPS. Cooper Companies’s revenue was up 2.9% compared to the same quarter last year. As a group, equities analysts forecast that Cooper Companies Inc will post 12.32 EPS for the current year.

In other news, Director Allan E. Rubenstein sold 1,335 shares of the stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $299.61, for a total value of $399,979.35. Following the completion of the transaction, the director now directly owns 3,591 shares in the company, valued at approximately $1,075,899.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Read More: What is the Producer Price Index (PPI)?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.